1419639-27-2

Upstream product

• 75937-12-1 6-(Boc-amino)-1-hexanol 
• 386297-97-8 2-[2-(4'-methoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl]-N,N-diethylacetamide 
• 868072-17-7 2-[2-(4'-hydroxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl]-N,N-diethylacetamide 
• 86536-92-7 6-((tert-butoxycarbonyl)amino)hexyl 4-methylbenzenesulfonate 
• 1419639-24-9 tert-butyl (6-(4-(3-(2-(diethylamino)-2-oxoethyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)phenoxy)hexyl)carbamate 
• 1419639-25-0 2-(2-(4-((6-aminohexyl)oxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide 
• 1419639-26-1 C₅₄H₈₇N₉O₉ 

Downstream Products

• 1419687-42-5 gadolinium(III) 2,2',2''-(10-(2-(6-(4-(3-(2-(diethylamino)-2-oxoethyl)5,7-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)phenoxy)hexylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate 

Relevant academic research and scientific papers

Synthesis and characterization of an MRI Gd-based probe designed to target the translocator protein

DPA-713 is the lead compound of a recently reported pyrazolo[1,5-a] pyrimidineacetamide series, targeting the translocator protein (TSPO 18 kDa), and as such, this structure, as well as closely related derivatives, have been already successfully used as p